Conversation on âImproving Competition to Lower Drug Pricesâ Emphasizes Need to Stop Abuse of the Patent System Last week, The Hill hosted an event titled, âPrescription for Change: Improving Competition to Lower Drug Prices.â During the event, lawmakers and a panel of drug
Welcome to the Pharmacy Benefit Brief. This brief is your monthly snapshot of news from Americaâs prescription drug supply chain including pharmacy benefit managers, independent pharmacies, and drug manufacturers. PLEASE, JUST THE FACTS ON PHARMACY COUNTS⊠When it comes to
The so-called âdelinkingâ policy made news last week with the introduction of H.R. 6283. Among several glaring problems — including a rejection of free market performance-based incentives that lower drug costs for consumers — if enacted, âdelinkingâ would hand a
Lawmakers Reintroduce Bill to Close Loopholes Allowing Big Drug Companies to Block Competition from More Affordable Options The Pharmaceutical Care Management Association, PCMA, applauds Senators Maggie Hassan (D-NH) and Mike Braun (R-IN) for recently reintroducing legislation, the Prescription Drug Competition Act,
(Washington, D.C.) â As part of its OnYourRxSide campaign, the Pharmaceutical Care Management Association (PCMA) today released a new video â âWhat is a PBM?â â detailing the role pharmacy benefit managers (PBMs) play in the prescription drug supply chain
(Washington, D.C.) â The Pharmaceutical Care Management Association (PCMA) released the following statement on the Senate Finance Committeeâs report on insulin pricing: âWe appreciate the Senate Finance Committeeâs focus on insulin pricing and share their urgency in addressing affordability and
Welcome to the Pharmacy Benefit Brief. This brief is your monthly snapshot of news from Americaâs prescription drug supply chain including pharmacy benefit managers, independent pharmacies, and drug manufacturers. PBMS ARE REDUCING PRESCRIPTION DRUG COSTS FOR PATIENTS⊠We hope this
Economic Analyses Shows âDelinkingâ Policy Hands Big Pharma a Financial Windfall totaling $32 Billion Annually (Washington, D.C.) â Pharmaceutical Care Management Association (PCMA) issued the following statement on the introduction of H.R. 6283, âDelinking Revenue from Unfair Gouging Actâ or
For millions of Americans, the prescription drug delivery system works: people, for the most part, can access the medications they need when they need them, and at the cost they expect and can afford. But âmillions of Americansâ does not
©2024 PCMA. All Rights Reserved.
